Write your message
Volume 4, Issue 7 (6-2020)                   زیست شناسی 2020, 4(7): 262-271 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Heydarloo H, Alizadeh Z. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. زیست شناسی. 2020; 4 (7) :262-271
URL: http://ijbio.ir/article-1-407-en.html
1- Immunology Asthma and Allergy Research Insititue, Tehran University of Medical Science, Tehran, I.R. of Iran
Immunology Asthma and Allergy Research Insititue, Tehran University of Medical Science, Tehran, I.R. of Iran, Immunology Asthma and Allergy Research Insititue, Tehran University of Medical Science, Tehran, I.R. of Iran , zalizade@yahoo.com
Abstract:   (164 Views)
Angiotensin converting enzyme-2 (ACE2) receptors mediate the entry into the cell of three strains of coronavirus: SARS-CoV, NL63 and SARS-CoV-2. ACE2 receptors are ubiquitous and widely expressed in the heart, vessels, gut, lung (particularly in type2 pneumocytes and macrophages), kidney, testisand brain. ACE2 is mostly bound to cell membranes and only scarcely present in the circulation in a soluble form. An important salutary function of membrane-bound and soluble ACE2 is the degradation of angiotensin II to angiotensin1-7. Consequently, ACE2 receptors limit several detrimental effects resulting from binding of angiotensin II to AT1 receptors, which include vasoconstriction, enhanced inflammation and thrombosis. The increased generation of angiotensin1-7 also triggers counter-regulatory protective effects through binding to G-protein coupled Mas receptors. Unfortunately, the entry of SARS-CoV2 into the cells through membrane fusion markedly down-regulates ACE2 receptors, with loss of the catalytic effect of these receptors at the external site of the membrane. Increased pulmonary inflammation and coagulation have been reported as unwanted effects of enhanced and unopposed angiotensin II effects via the ACE→Angiotensin II→AT1 receptor axis. Clinical reports of patients infected with SARS-CoV-2 show that several features associated with infection and severity of the disease (i.e., older age, hypertension, diabetes, cardiovascular disease) share a variable degree of ACE2 deficiency. We suggest that ACE2 down-regulation induced by viral invasion may be especially detrimental in people with baseline ACE2 deficiency associated with the above conditions. The additional ACE2 deficiency after viral invasion might amplify the dysregulation between the ‘adverse’ ACE→Angiotensin II→AT1 receptor axis and the ‘protective’ ACE2→Angiotensin1-7→Mas receptor axis. In the lungs, such dysregulation would favor the progression of inflammatory and thrombotic processes triggered by local angiotensin II hyperactivity unopposed by angiotensin1-7. In this setting, recombinant ACE2, angiotensin1-7 and angiotensin II type 1 receptor blockers could be promising therapeutic approaches in patients with SARS-CoV-2 infection. Abbreviations: ADAM17, disintegrin and metalloproteinase 17; ACE, angiotensin-converting enzyme; ACE2, angiotensin-converting enzyme 2; COVID-19, 2019 novel coronavirus disease; DABK, des-Arg9 bradykinin; IL, interleukin; NL63, human coronavirus NL63; RAAS, renin-angiotensin-aldosterone system; SARS, severe acute respiratory syndrome; SARS-CoV, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome novel coronavirus; TMPRSS2, transmembrane protease serine 2
     
Type of Study: Review Paper | Subject: Innovation
Received: 2020/07/13 | Accepted: 2020/06/30 | Published: 2020/06/30

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Biological Science Promotion

Designed & Developed by : Yektaweb